ARTICLE | Company News
Dyax, Novellus Biopharma AG sales and marketing update
February 11, 2013 8:00 AM UTC
Dyax and Novellus partnered to develop and commercialize Kalbitor ecallantide in select regions in Latin America to treat hereditary angioedema (HAE) and other angioedema indications. Novellus will h...